Ascendiant Capital Markets

Analysts at Ascendiant Capital Markets believe that shares of Activision Blizzard (NASDAQ: ATVI) are attractive going into the company's second quarter results. The analyst, Edward Woo, is expecting Activision Blizzard to report an inline quarterly report when the company releases its...

Intel (NASDAQ: INTC) shares soared Wednesday on earnings news, but analysts were sounding cautious. "Intel's shares are acting as if the PC market had returned to stable growth and real success is being seen in tablets and smartphones," Ascendiant Capital's Cody G. Acree said in a note. Late...

Shares of Intel (NASDAQ: INTC) are up more than 8.5 percent Wednesday after a slew of analysts released coverage on the company. Morgan Stanley reiterated an Equal-weight rating and raised the company's price target from $28 to $30. Barclays maintained an Equal-Weight rating, while...

In a report published Wednesday, Ascendiant Capital Market analyst Cody G. Acree reiterated a Buy rating and $14.00 price target on Applied Micro Circuits (NASDAQ: AMCC). In the report, Ascendiant Capital Market noted, “We recently had Applied Micro, APM, participate in our Quarterly Management...

In a report published Wednesday, Ascendiant Capital Markets analyst Keay Nakae initiated coverage on Alliqua (NASDAQ: ALQA) with a Buy rating and $9.00 price target. In the report, Ascendiant Capital Markets noted, “We are initiating coverage of ALQA with a BUY rating and 12-month price target of $...

In a report published Thursday, Ascendiant Capital Markets analyst Keay Nakae downgraded the rating on PhotoMedex (NASDAQ: PHMD) from Buy to Hold, and removed the $18.00 price target. In the report, Ascendiant Capital Markets noted, “The acquisition of LCA Vision has now been completed. The...

In a report published Tuesday, Ascendiant Capital Markets analyst Marla Backer initiated coverage on IMAX Corporation (NYSE: IMAX) with a Buy rating and $32.00 price target. In the report, Ascendiant Capital Markets noted, “IMAX has become a key premium technology in the exhibitor industry, in our...

In a report published Thursday, Ascendiant Capital Markets analyst Marla Backer reiterated a Buy rating on DreamWorks Animation SKG (NASDAQ: DWA), and raised the price target from $32.00 to $38.00. In the report, Ascendiant Capital Markets noted, “DVD sales and rental data indicate that the...

In a report published Friday, Ascendiant Capital Markets analyst Christopher Bamman downgraded the rating on DXP Enterprises (NASDAQ: DXPE) from Buy to Neutral. In the report, Ascendiant Capital Markets noted, “Strong price movement prompts rating change to Neutral from Buy. The shares of DXP...

In a report published Thursday, Ascendiant Capital Markets analyst Carter W. Driscoll initiated coverage on Westport Innovations (NASDAQ: WPRT) with a Buy rating and $29.00 price target. In the report, Ascendiant Capital Markets noted, “Initiating coverage with a BUY rating and $29 price target....

In a report published Friday, Ascendiant Capital Markets analyst Christopher Bamman downgraded the rating on Curtiss-Wright (NYSE: CW) from Buy to Neutral. In the report, Ascendiant Capital Markets noted, “Given that the shares have reached our target price of $50 and target multiple of 15.0x our...

In a report published Friday, Ascendiant Capital Markets analyst Marla Backer initiated coverage on Lions Gate Entertainment (NYSE: LGF) with a Buy rating and $40.00 price target. In the report, Ascendiant Capital Markets noted, “LGF is transitioning from ‘mini-major' to major studio, in our view...

In a report published Thursday, Ascendiant Capital Markets analyst Keay Nakae downgraded the rating on Repros Therapeutics (NASDAQ: RPRX) from Strong Buy to Buy, but reiterated the $25.00 price target. In the report, Ascendiant Capital Markets noted, “Yesterday, the company announced that the FDA...

In a report published Friday, Ascendiant Capital Markets analyst Christopher Bamman downgraded the rating on Dover Corporation (NYSE: DOV) from Buy to Neutral. In the report, Ascendiant Capital Markets noted, “Given the reduction in the midpoint of managements 2013 EPS guidance to $5.61 from $5.64...